The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief executive officer Michele Buck told analysts in a conference call on fiscal 2024 ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

About 1 in 8 U.S. adults have taken Ozempic or similar medications used to treat Type 2 diabetes and obesity. While these ...

Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

A new weight loss drug target may help reduce appetite and burn calories without causing sickness, research suggests. The ...